Klow

CAS 67727-97-3 / 49557-75-7 / 137525-51-0 / 77591-33-4 · Tissue and Regenerative Research

80 MG

$89.00

✔ ORDER NOW · SHIPS TODAY

Bulk Discount

⚠ RESEARCH USE ONLY

This product is sold strictly for in vitro laboratory research use only. Not for human or animal consumption, diagnostic use, or therapeutic application. Purchasers must be qualified researchers or authorized purchasers for a research institution.

CERTIFICATE OF ANALYSIS

Third party tested for: Purity · ID · Quantity

BATCH #202610071025 View All →

View on PubChem→

Klow Overview

Klow is an 80 mg research blend combining four peptides in a single lyophilized vial: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg). It is offered for researchers studying these compounds together under shared experimental conditions.

In research models, the individual components have been examined for roles in tissue remodeling, extracellular-matrix signaling, angiogenesis, cell migration and inflammatory-pathway modulation.

Reference: Pickart L. et al. (2018), Int J Mol Sci, 19(7).

History

Klow builds on earlier multi-peptide research blends that pair the copper-binding tripeptide GHK-Cu with BPC-157 (a pentadecapeptide derived from a gastric protein) and TB-500 (a synthetic fragment of thymosin beta-4). KPV, a C-terminal tripeptide of alpha-MSH, extends the combination toward inflammation-related signaling research.

Reference: Goldstein A. L. et al. (2012), Expert Opin Biol Ther, 12(1), 37-51.

Klow Composition

GHK-Cu: 50 mg

BPC-157: 10 mg

TB-500: 10 mg

KPV: 10 mg

Total: 80 mg

Research Findings

Each component has its own body of preclinical literature; research on the combined blend itself is limited. Published work on the individual peptides describes activity in wound-healing, angiogenesis, cell-migration and inflammatory-signaling models.

Key Areas of Research:

GHK-Cu: Extracellular-matrix and collagen-related gene expression in vitro
BPC-157: Tissue-repair and angiogenesis markers in animal models
TB-500: Actin regulation and cell migration in cultured cells
KPV: NF-kB-related inflammatory signaling in epithelial cell models

Because each peptide acts through different pathways, Klow is intended as a research tool for comparing and combining these signaling axes in vitro and in preclinical models.

References: Sikiric P. et al. (2011), Curr Pharm Des, 17(16), 1612-1632.; Dalmasso G. et al. (2008), Gastroenterology, 134(1), 166-178.

References

Frequently Asked Questions

Everything you need to know about our products and processes.

Each vial contains the exact quantity listed on the label. The 80 mg vial contains a lyophilized blend of GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg). Research-grade purity supports accurate dosing for experimental protocols.

Peptides ship as lyophilized powder. Every order includes a complimentary vial of bacteriostatic water for reconstitution. Any additional supplies (syringes, mixing vials, etc.) must be sourced separately by the research institution.

Sealed lyophilized peptide remains stable for approximately 2 years when stored properly. After reconstitution, the solution should be refrigerated and typically retains stability for several weeks depending on temperature and handling conditions.

No. Our products are supplied strictly for in vitro laboratory research. Because these compounds are not authorized for use on humans or animals outside approved research settings, we do not provide usage or dosing instructions.

All peptides are guaranteed to be at least 98% pure, verified by HPLC and mass spectrometry. A Certificate of Analysis is available for every batch.

Keep lyophilized peptides in a cool, dry place away from direct heat and light. Once reconstituted, refrigerate the solution to maintain stability and preserve peptide integrity.